Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
Sponsor: Surgenex
Summary
The purpose of this study is to compare Pellograft to standard of care modalities in treating diabetic foot ulcers in human subjects, and to compare Sanograft to standard of care in treating venous leg ulcers. The study will demonstrate wound healing outcomes with comparators including time to wound epithelialization, decrease in wound size, and total number of study product applications towards healing outcome. This information is important to the Centers for Medicare and Medicaid Services (CMS) and other payors in determining coverage policy and reimbursement for this product category.
Official title: A Randomized Post-Market Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating Diabetic Foot Ulcers (DFU) and SanoGraft® in Treating Venous Leg Ulcers (VLU) to SOC Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2024-06-23
Completion Date
2027-09-08
Last Updated
2026-04-07
Healthy Volunteers
No
Conditions
Interventions
PelloGraft
dual layer amnion/chorion-derived allograft
SanoGraft
single layer amnion-derived allograft
Locations (2)
ILD Research
Vista, California, United States
Tulsa Wound Center
Tulsa, Oklahoma, United States